ES2556253R1 - Preparaciones antifúngicas destinadas al tratamiento local de onicomicosis - Google Patents

Preparaciones antifúngicas destinadas al tratamiento local de onicomicosis Download PDF

Info

Publication number
ES2556253R1
ES2556253R1 ES201531001A ES201531001A ES2556253R1 ES 2556253 R1 ES2556253 R1 ES 2556253R1 ES 201531001 A ES201531001 A ES 201531001A ES 201531001 A ES201531001 A ES 201531001A ES 2556253 R1 ES2556253 R1 ES 2556253R1
Authority
ES
Spain
Prior art keywords
local
antifungal preparations
onychomycosis
preparations intended
onychomycosis treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES201531001A
Other languages
English (en)
Other versions
ES2556253B2 (es
ES2556253A2 (es
Inventor
Pascal VIANT
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
R&d Pharm
R&D PHARMA
Original Assignee
R&d Pharm
R&D PHARMA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by R&d Pharm, R&D PHARMA filed Critical R&d Pharm
Publication of ES2556253A2 publication Critical patent/ES2556253A2/es
Publication of ES2556253R1 publication Critical patent/ES2556253R1/es
Application granted granted Critical
Publication of ES2556253B2 publication Critical patent/ES2556253B2/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015Drug-containing film-forming compositions, e.g. spray-on
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Preparaciones antifúngicas destinadas al tratamiento local de onicomicosis.#La invención se refiere a las preparaciones antifúngicas en disolución en gamma-butirolactona, útiles para el tratamiento local de onicomicosis.#El efecto terapéutico puede reforzarse mediante la acción queratolítica del ácido salicílico y que puede hacerse que sean ventajosamente viscosas, gelificadas o filmógenas, con o sin coloración.
ES201531001A 2014-07-11 2015-07-10 Preparaciones antifúngicas destinadas al tratamiento local de onicomicosis Active ES2556253B2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1401569A FR3023484B1 (fr) 2014-07-11 2014-07-11 Preparations antifongiques destinees au traitement local des onychomycoses
FR140156 2014-07-11

Publications (3)

Publication Number Publication Date
ES2556253A2 ES2556253A2 (es) 2016-01-14
ES2556253R1 true ES2556253R1 (es) 2016-02-02
ES2556253B2 ES2556253B2 (es) 2016-09-19

Family

ID=52358801

Family Applications (1)

Application Number Title Priority Date Filing Date
ES201531001A Active ES2556253B2 (es) 2014-07-11 2015-07-10 Preparaciones antifúngicas destinadas al tratamiento local de onicomicosis

Country Status (3)

Country Link
CH (1) CH709877B1 (es)
ES (1) ES2556253B2 (es)
FR (1) FR3023484B1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6800209B2 (ja) 2015-08-13 2020-12-16 ビーエイエスエフ・ソシエタス・エウロパエアBasf Se 水溶性溶媒、無機増粘剤及びアルコキシレートを含む非水性殺有害生物剤懸濁液

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988006884A1 (en) * 1987-03-09 1988-09-22 Lengyelne Horvath Gyoengyi A pharmaceutical composition used for the topical treatment of nail mycosis and a process for preparing same
US5487776A (en) * 1994-03-17 1996-01-30 Nimni; Marcel Anti-fungal nail lacquer and method therefor
WO2001043547A1 (en) * 1999-12-16 2001-06-21 Isp Investments Inc. Fast drying biocidal preservative composition
MXPA03004049A (es) * 2003-05-08 2004-11-10 Acosta Rita Guadal Escorihuela Composicion topica para el tratamiento de micosis en las unas y procedimiento de obtencion.
RU2013120455A (ru) * 2013-04-30 2014-11-10 Закрытое Акционерное Общество "Вертекс" Комбинированный препарат для лечения грибковых заболеваний ногтей

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4672078A (en) * 1985-07-03 1987-06-09 Schering-Plough Corporation Urea stabilized with a lactone in various pharmaceutical and cosmetic preparations
WO2010091045A2 (en) * 2009-02-05 2010-08-12 Advanced Technology Materials, Inc. Non-fluoride containing composition for the removal of polymers and other organic material from a surface

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988006884A1 (en) * 1987-03-09 1988-09-22 Lengyelne Horvath Gyoengyi A pharmaceutical composition used for the topical treatment of nail mycosis and a process for preparing same
US5487776A (en) * 1994-03-17 1996-01-30 Nimni; Marcel Anti-fungal nail lacquer and method therefor
WO2001043547A1 (en) * 1999-12-16 2001-06-21 Isp Investments Inc. Fast drying biocidal preservative composition
MXPA03004049A (es) * 2003-05-08 2004-11-10 Acosta Rita Guadal Escorihuela Composicion topica para el tratamiento de micosis en las unas y procedimiento de obtencion.
RU2013120455A (ru) * 2013-04-30 2014-11-10 Закрытое Акционерное Общество "Вертекс" Комбинированный препарат для лечения грибковых заболеваний ногтей

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CICLOCHEM UÑAS Prospecto; 02.01.2013 [recuperado el 22.01.2016]. Recuperado de Internet: http://www.vademecum.es/medicamento-ciclochem unas_prospecto_61719 *

Also Published As

Publication number Publication date
ES2556253B2 (es) 2016-09-19
ES2556253A2 (es) 2016-01-14
CH709877B1 (fr) 2019-04-30
FR3023484A1 (fr) 2016-01-15
FR3023484B1 (fr) 2018-10-12
CH709877A2 (fr) 2016-01-15

Similar Documents

Publication Publication Date Title
CO2019014414A2 (es) Moléculas de anticuerpo que se unen a cd73 y usos de las mismas
GT201600185A (es) Moléculas de anticuerpo que se unen a lag-3 y usos de las mismas
DK3430086T3 (da) Siliconegel, der klæber til huden
DK3305680T3 (da) Lukke til beholdere
BR112017007379A2 (pt) moléculas de anticorpo para pd-l1 e usos das mesmas
DK3229810T3 (da) Phospholipid-ether-analoger som kræftrammende lægemiddelvehikler
BR112016021011A2 (pt) composição tópica e usos de um composto
BR112017023041A2 (pt) emulsões tópicas de filtro solar.
EA201790410A1 (ru) Содержащая цинеол композиция для назального применения
BR112016017464A2 (pt) uso de ácido guanidinoacético e/ ou creatina para aumentar a taxa de eclosão de ovos.
EA201890212A1 (ru) Новое применение сульфата декстрана
DK3485181T3 (da) Forbedringer i eller vedrørende forbindelsesindretninger
DK3352804T3 (da) Artikel, der klæber til huden
BR112018002283A2 (pt) Composição para administração tópica a um sujeito, e, formulação tópica
DK3313459T3 (da) Artikel, der klæber til huden
BR112017007753A2 (pt) uso de uma composição cosmética que compreende ácido 10-hidroxiesteárico.
DK3369429T3 (da) Farmaceutisk sammensætning tiltænkt at blive administreret til næseslimhinden
FR3023506B1 (fr) Applicateur de liquide, notamment de maquillage
ES2556253R1 (es) Preparaciones antifúngicas destinadas al tratamiento local de onicomicosis
BR112016026814A2 (pt) 2,2,2-trifluoroetil-tiadiazinas, intermediário, seu uso e seu processo de preparação, e composição farmacêutica
DK3490577T3 (da) Sammensætninger til hud, omfattende turmeroner
EA201991993A1 (ru) Применение фенилкреатина в качестве ноотропного агента
MA44244A (fr) Formulation pour traiter la migraine
TH183269B (th) องค์ประกอบทางยาที่ใช้กับผิวหนัง
GB2540931B (en) Improvements in or relating to beauty treatments

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 2556253

Country of ref document: ES

Kind code of ref document: B2

Effective date: 20160919